Items tagged with Drug-resistant TB
India: Drug-resistant TB higher among children than expected (post)
While detection of tuberculosis (TB) in children remains a challenge, it has now emerged that multidrug-resistant TB (MDR-TB) is higher among children than expected. This has been described as a “worrying trend” by the Union Health Ministry.
The challenges of treating drug-resistant TB in India (post)
'Be prepared to take medicines for a long, long time.' Once considered a 'disease of the past', TB has had a resurgence.
Otsuka and R-Pharm announce licensing agreement to commercialize Deltyba™ in Russia and CIS countries (post)
Otsuka Pharmaceutical Co. Ltd. (Otsuka) and the Russian pharmaceutical company R-Pharm JSC (R-Pharm) have entered into a licensing agreement to manufacture and commercialize Deltyba™ (delamanid) for the treatment of adults with pulmonary multidrug-resistant tuberculosis (MDR-TB) in the Russian Federation and the Commonwealth of Independent States (CIS).
Denying access to bedaqualine in India costs lives (post)
As physicians managing the so-called Patna patient—an 18-year-old woman who took the Indian government to court after being denied access to bedaqualine—we commend Amber Kunkel and colleagues on their forthright article.1 The woman's case is emblematic of the desperation of the many patients with advanced drug resistance and with few therapeutic options that we encounter in our clinic. India's National Tuberculosis Program's (RNTCP) insistence on reserving bedaqualine for patients who have at least three susceptible drugs in the background regimen,2 denies this drug to the very patients who would most benefit from it, especially since it doubles the chance of a cure.3 It worries us that such patients, denied access to a life-saving drug, are compelled to move the judiciary to access it. The theoretical fear of protecting a drug has sadly taken precedence over protecting lives.
IAS 2017: XDR-TB emerges in 1990s in South Africa fueled by HIV (post)
PARIS – Extensively drug-resistant tuberculosis (XDR-TB) emerged and was widely transmitted in South Africa long before it was spotted by public health surveillance efforts, and at least a decade earlier than the first reported outbreak in 2005, a presentation Monday (July 24) showed. The start of the spread was concurrent with the steep rise in both HIV and TB incidence in the early 1990s.
US govt supports introduction of new TB drug to PNG (post)
The United States Agency for International Development (USAID) is working with partner organisations to introduce a new drug into Papua New Guinea called bedaquiline, the first new drug for tuberculosis in over 45 years.
Treatment initiation among persons diagnosed with drug-resistant TB in Johannesburg, South Africa (post)
Abstract
Mylan gets DCGI approval to market anti-TB drug delamanid (post)
Mylan’s TB drug delamanid will be limited to those patients who have stopped responding to most of first and second line of treatment
TB drug may work better than others in its class (post)
Computer simulations suggest moxifloxacin outperforms two other drugs when doses are missed
Page 44 of 117 · Total posts: 0
←First 43 44 45 Last→